# Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

> **NCT02568280** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 42 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Faster-acting insulin aspart
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT02568280
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-06
- **Primary completion:** 2016-04-25
- **Final completion:** 2016-04-25
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02568280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02568280, "Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02568280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*